QuantumScape Corporation (QS)
NYSE: QS · Real-Time Price · USD
3.960
-0.020 (-0.50%)
At close: Apr 24, 2025, 4:00 PM
3.960
0.00 (0.00%)
Pre-market: Apr 25, 2025, 4:38 AM EDT
Company Description
QuantumScape Corporation, together with its subsidiaries, focuses on the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications in the United States.
The company was founded in 2010 and is headquartered in San Jose, California.
QuantumScape Corporation
Country | United States |
Founded | 2010 |
Industry | Auto Parts |
Sector | Consumer Discretionary |
Employees | 800 |
CEO | Siva Sivaram |
Contact Details
Address: 1730 Technology Drive San Jose, California 95110 United States | |
Phone | 408 452 2000 |
Website | quantumscape.com |
Stock Details
Ticker Symbol | QS |
Exchange | NYSE |
Stock Type | Common Stock |
Share Class | Class A Shares |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001811414 |
CUSIP Number | 74767V109 |
ISIN Number | US74767V1098 |
Employer ID | 85-0796578 |
SIC Code | 3690 |
Key Executives
Name | Position |
---|---|
Dr. Siva Sivaram | President, Chief Executive Officer and Director |
Prof. Friedrich Prinz Ph.D. | Co-Founder, Chief Scientific Advisor and Board Member |
Dr. Timothy Holme | Co-Founder and Chief Technology Officer |
Kevin Hettrich | Chief Financial Officer |
Dr. Mohit Singh | Chief Development Officer |
John Joseph Saager III | Head of Investor Relations |
Michael O. McCarthy III | Chief Legal Officer and Head of Corporate Development |
Pamela Fong | Chief of Human Resources Operations |
Daniel Braithwaite | Senior Director of Cell Manufacturing |
Chris Dekmezian | Principal Product Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 24, 2025 | ARS | Filing |
Apr 24, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 24, 2025 | DEF 14A | Other definitive proxy statements |
Apr 23, 2025 | 8-K | Current Report |
Mar 7, 2025 | SCHEDULE 13D/A | Filing |
Mar 4, 2025 | 144 | Filing |
Feb 26, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
Feb 26, 2025 | 10-K | Annual Report |
Feb 21, 2025 | 144 | Filing |
Feb 21, 2025 | 144 | Filing |